Investigation of Metabolic Bone Diseases, Molecular Cellular and Genetic Determinants of Bone Structure and Formation, Integrative Physiology of the Skeleton
Primary Hyperparathyroidism and Vitamin D Deficiency
Shonni J. Silverberg, M.D., Columbia University College of Physicians & Surgeons,
New York, New York, USA
FGF-23/MEPE/TIO/XLH and Vitamin D Metabolism
Marc K. Drezner, M.D., University of Wisconsin, Madison, Wisconsin, USA
Vitamin D–Resistant Diseases
Uri A. Liberman, M.D., Ph.D., Tel Aviv University, Tel Aviv, Israel
Supported by educational grants from Eli Lilly and Company, Merck & Co., Inc., NPS Pharmaceuticals, The Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals and sanofi-aventis, US) and Immunodiagnostic Systems.
Funding for this conference was made possible (in part) by Grant AR055036 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases and the Office of Dietary Supplements. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Length: 75 minutes